"Innovative" and "provocative" therapies with mesenchymal stem cells in case of progressive multiple sclerosis have shown good results.
Scientists from Stanford University School of Medicine have reported the success of the world's first complete digital randomized clinical trial. A document showing the results of the work was published in The Lancet Digital Health.
Swedish medicines manufacturer Orexo, best known for its medicines for opioid addiction, has licensed an innovative digital therapy for alcohol addiction.
A blood test for detection of inflammation can foresee an individual risk of developing heart and vascular diseases or early death 40 years before real problems arise. The authors of the development are the scientists of Sloan Kettering Cancer Center.
Scientists have found that Wolbachia bacterium used to fight mosquitoes can be a very cheap and effective way to fight dengue virus.
A group of scientists from NUST MISiS, has created a new material for medical implants that simplifies recovery from fractures, Remedium reports. The secret is to use platinum and iron nanoparticles. They allow to destroy up to 98% of harmful bacteria, as a result to reduce the risk of postoperative infections.
Kadimastem Company from Israeli has reported that the rodent trials of the new IsletRx anti-diabetes drug have been successfully completed. As Xinhua notes, therapy is based on working pancreatic cells and a unique microencapsulation technology. The experiments have proved the safety of the delivery method and the effectiveness of therapy (blood sugar levels were within the normal range).
The University of Northern Carolina has established that mainly cancer develops as a result of the interaction of bacteria and glycoprotein MUC1, which covers the surface of epithelial cells in the body. According to Eurolab, MUC1 is present in almost all glandular epithelial cells.
Oramed Pharmaceuticals Company from Israeli has reported the successful test of insulin capsules helping to control diabetes. As Xinhua notes, a drug known as ORMD-0801 may become the first oral form of insulin.
American researchers are working on a universal flu vaccine that should work against both seasonal and pandemic influenza. Clinical examination results were very encouraging - the vaccine showed efficacy.